RenovoRx, Inc. (RNXT)
NCM · Common · CUSIP 75989R107
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for RNXT and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
75989R107
Market Cap
Micro Cap
IPO
8/26/2021 · $9/unit
Business: RenovoRx, Inc. is a biopharmaceutical company headquartered in Silicon Valley, California, has developed a therapy platform targeting difficult-to-treat tumors.

Company Contact

CEO
Shaun R. Bagai
CFO
Mark Voll
Headquarters
4546 El Camino Real, Suite B1, Los Altos, CA 94022
Phone
650-284-4433
Investor Relations
Valter Pinto, KCSA Strategic Communications · 212-896-1254 · renovorx@kcsa.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »